Related references
Note: Only part of the references are listed.Skeletal impact of 17β-estradiol in T cell-deficient mice: age-dependent bone effects and osteosarcoma formation
Julia N. Cheng et al.
CLINICAL & EXPERIMENTAL METASTASIS (2020)
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
Laura Fachal et al.
NATURE GENETICS (2020)
Phosphoproteome Analysis Reveals Estrogen-ER Pathway as a Modulator of mTOR Activity Via DEPTOR
Rafael Cuesta et al.
MOLECULAR & CELLULAR PROTEOMICS (2019)
Patient-Derived Xenograft Models of Breast Cancer and Their Application
Takahiko Murayama et al.
CELLS (2019)
Curcumin, but not curcumin-glucuronide, inhibits Smad signaling in TGFβ-dependent bone metastatic breast cancer cells and is enriched in bone compared to other tissues
Andrew G. Kunihiro et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2019)
Early TGF-β inhibition in mice reduces the incidence of breast cancer induced bone disease in a myeloid dependent manner
Denise Buenrostro et al.
BONE (2018)
MSK1 regulates luminal cell differentiation and metastatic dormancy in ER+ breast cancer
Sylwia Gawrzak et al.
NATURE CELL BIOLOGY (2018)
Signaling pathways and steroid receptors modulating estrogen receptor a function in breast cancer
Rasmus Siersbaek et al.
GENES & DEVELOPMENT (2018)
Enrichment and detection of bone disseminated tumor cells in models of low tumor burden
Miranda E. Sowder et al.
SCIENTIFIC REPORTS (2018)
CDK4/6 inhibition in breast cancer: current practice and future directions
Sonia Pernas et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2018)
Non-Smad Signaling Pathways of the TGF-β Family
Ying E. Zhang
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)
Steroid Hormone Receptor Positive Breast Cancer Patient-Derived Xenografts
Shawna B. Matthews et al.
HORMONES & CANCER (2017)
Advances in the treatment of advanced oestrogen-receptor-positive breast cancer
Nicholas C. Turner et al.
LANCET (2017)
Targeting TGF-β Signaling for Therapeutic Gain
Rosemary J. Akhurst
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)
Oestrogen receptor positive breast cancer metastasis to bone: inhibition by targeting the bone microenvironment in vivo
I. Holen et al.
CLINICAL & EXPERIMENTAL METASTASIS (2016)
Myeloid-specific TGF-β signaling in bone promotes basic-FGF and breast cancer bone metastasis
X. Meng et al.
ONCOGENE (2016)
Patient-derived xenograft (PDX) models in basic and translational breast cancer research
Lacey E. Dobrolecki et al.
CANCER AND METASTASIS REVIEWS (2016)
Aromatase expression and regulation in breast and endometrial cancer
Hong Zhao et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2016)
Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the, bone marrow
Rachelle W. Johnson et al.
NATURE CELL BIOLOGY (2016)
Murine models of breast cancer bone metastasis
Laura E. Wright et al.
BONEKEY REPORTS (2016)
Breast Cancer Subtypes Predispose the Site of Distant Metastases
Abha Soni et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2015)
Enhanced MAF Oncogene Expression and Breast Cancer Bone Metastasis
Milica Pavlovic et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
Enhanced MAF Oncogene Expression and Breast Cancer Bone Metastasis
Milica Pavlovic et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Optimal management of hormone receptor positive metastatic breast cancer in 2016
Tomas Reinert et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2015)
Time-dependent risk of developing distant metastasis in breast cancer patients according to treatment, age and tumour characteristics
E. Colzani et al.
BRITISH JOURNAL OF CANCER (2014)
Targeting the PI3K/AKT/mTOR pathway in estrogen receptor-positive breast cancer
Eva Maria Ciruelos Gil
CANCER TREATMENT REVIEWS (2014)
Zoledronic Acid Has Differential Antitumor Activity in the Pre- and Postmenopausal Bone Microenvironment In Vivo
Penelope D. Ottewell et al.
CLINICAL CANCER RESEARCH (2014)
Luminal breast cancer metastases and tumor arousal from dormancy are promoted by direct actions of estradiol and progesterone on the malignant cells
Ndiya Ogba et al.
BREAST CANCER RESEARCH (2014)
Discordant hormone receptor and human epidermal growth factor receptor 2 status in bone metastases compared to primary breast cancer
Gaetano Aurilio et al.
ACTA ONCOLOGICA (2013)
Myeloid-Derived Suppressor Cells Function as Novel Osteoclast Progenitors Enhancing Bone Loss in Breast Cancer
Anandi Sawant et al.
CANCER RESEARCH (2013)
Standardized Nomenclature, Symbols, and Units for Bone Histomorphometry: A 2012 Update of the Report of the ASBMR Histomorphometry Nomenclature Committee
David W. Dempster et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Curcuminoids Block TGF-β Signaling in Human Breast Cancer Cells and Limit Osteolysis in a Murine Model of Breast Cancer Bone Metastasis
Laura E. Wright et al.
JOURNAL OF NATURAL PRODUCTS (2013)
TGF-β Signaling in Myeloid Cells Is Required for Tumor Metastasis
Yanli Pang et al.
CANCER DISCOVERY (2013)
Incidence, consequences and treatment of bone metastases in breast cancer patients Experience from a single cancer centre
I. Kuchuk et al.
JOURNAL OF BONE ONCOLOGY (2013)
RANKL inhibition combined with tamoxifen treatment increases anti-tumor efficacy and prevents tumor-induced bone destruction in an estrogen receptor-positive breast cancer bone metastasis model
Jude Canon et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Impact of Breast Cancer Subtypes and Treatment on Survival: An Analysis Spanning Two Decades
Reina Haque et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)
Luminal breast cancer metastasis is dependent on estrogen signaling
Vidya Ganapathy et al.
CLINICAL & EXPERIMENTAL METASTASIS (2012)
Everolimus in Postmenopausal Hormone-Receptor-Positive Advanced Breast Cancer
Jose Baselga et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Osteoclasts in Multiple Myeloma Are Derived from Gr-1+CD11b+Myeloid-Derived Suppressor Cells
Junling Zhuang et al.
PLOS ONE (2012)
Myeloid-derived suppressor cells expand during breast cancer progression and promote tumor-induced bone destruction
Sabrina Danilin et al.
ONCOIMMUNOLOGY (2012)
ABCC5 supports osteoclast formation and promotes breast cancer metastasis to bone
Anna A. Mourskaia et al.
BREAST CANCER RESEARCH (2012)
Acquisition of metastatic tissue from patients with bone metastases from breast cancer
J. F. Hilton et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Anti-Transforming Growth Factor β Antibody Treatment Rescues Bone Loss and Prevents Breast Cancer Metastasis to Bone
Swati Biswas et al.
PLOS ONE (2011)
Estrogen receptor alpha attenuates transforming growth factor-beta signaling in breast cancer cells independent from agonistic and antagonistic ligands
Matthias B. Stope et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Estrogen Inhibits Transforming Growth Factor β Signaling by Promoting Smad2/3 Degradation
Ichiaki Ito et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Inhibition of TGF-β Signaling by 1D11 Antibody Treatment Increases Bone Mass and Quality In Vivo
James R. Edwards et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Targeting the Transforming Growth Factor-β pathway inhibits human basal-like breast cancer metastasis
Vidya Ganapathy et al.
MOLECULAR CANCER (2010)
Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis
M. Petersen et al.
ONCOGENE (2010)
Breast cancer metastasis to the bone: mechanisms of bone loss
Yu-Chi Chen et al.
BREAST CANCER RESEARCH (2010)
Elevated Aromatase Expression in Osteoblasts Leads to Increased Bone Mass Without Systemic Adverse Effects
Klara Sjogren et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Imaging transforming growth factor-β signaling dynamics and therapeutic response in breast cancer bone metastasis
Manav Korpal et al.
NATURE MEDICINE (2009)
Transforming growth factor-β1 is the predominant isoform required for breast cancer cell outgrowth in bone
A. A. Mourskaia et al.
ONCOGENE (2009)
17-β-Estradiol Inhibits Transforming Growth Factor-β Signaling and Function in Breast Cancer Cells via Activation of Extracellular Signal-Regulated Kinase through the G Protein-Coupled Receptor 30
Burkhard Kleuser et al.
MOLECULAR PHARMACOLOGY (2008)
Estrogen-induced activation of mammalian target of rapamycin is mediated via tuberin and the small GTPase ras homologue enriched in brain
Jane Yu et al.
CANCER RESEARCH (2006)
Osteoprotegerin overexpression by breast cancer cells enhances orthotopic and osseous tumor growth and contrasts with that delivered therapeutically
JL Fisher et al.
CANCER RESEARCH (2006)
The tumor suppressor Smad4 is required for transforming growth factor β-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells
M Deckers et al.
CANCER RESEARCH (2006)
Mouse models of breast cancer metastasis
Anna Fantozzi et al.
BREAST CANCER RESEARCH (2006)
Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway
YB Kang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Breast cancer metastasis to bone: Mechanisms of osteolysis and implications for therapy
W Kozlow et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2005)
Determinants of rapamycin sensitivity in breast cancer cells
WC Noh et al.
CLINICAL CANCER RESEARCH (2004)
A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases
JJ Yin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
A multigenic program mediating breast cancer metastasis to bone
YB Kang et al.
CANCER CELL (2003)
Transforming growth factor-β stimulates parathyroid hormone-related protein and osteolytic metastases via Smad and mitogen-activated protein kinase signaling pathways
SM Käkönen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Transforming growth factor β regulates parathyroid hormone-related protein expression in MDA-MB-231 breast cancer cells through a novel Smad/Ets synergism.
RK Lindemann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Cross-talk between transforming growth factor-β and estrogen receptor signaling through Smad3
T Matsuda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
TGF beta 1 and TGF beta 2 mRNA and protein expression in human bone samples
S Hering et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2001)
TGF-β1 stimulates expression of the aromatase (CYP19) gene in human osteoblast-like cells and THP-1 cells
M Shozu et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2000)
Share Paper
